| Chemical modification of interleukin-10 with mannose 6-phosphate groups yields a liver-selective cytokine. | |
| | |
MedLine Citation:
|
PMID: 17312017 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Cytokines are considered a promising immunotherapy for chronic diseases, because of their potency and fundamental roles in pathological processes. However, their therapeutic use is limited because of their poor pharmacokinetics and pleiotropic effects in various organs. These problems may be overcome by cell-specific delivery of the cytokine. This approach involves chemical modification of the protein with homing devices that recognize receptors on target cells. The cytokine interleukin-10 (IL10) may be valuable as a therapeutic cytokine for patients with liver cirrhosis. However, its rapid renal elimination and general immunosuppressive activities limit therapeutic use. We therefore aim to target this cytokine in the liver, in particular to fibrogenic hepatic stellate cells (HSCs). We show that IL10 is successfully modified with mannose 6-phosphate (M6P), which is a homing device for the mannose 6-phosphate/insulin-like growth factor II (M6P/IGFII) receptor expressed on activated HSCs. Chemical modification did not diminish IL10 efficacy with regard to in vitro anti-inflammatory (lipopolysaccharide-stimulated tumor necrosis factor alpha release) and antifibrotic (collagen deposition and degradation) activities. Biodistribution studies with radiolabeled M6P-IL10 and IL10 in rats with liver fibrosis showed that modification with M6P groups induced a shift in the distribution from the kidneys (IL10) to the liver (M6P-IL10). Hepatocellular binding of M6P-IL10 occurred via M6P/IGFII receptors and scavenger receptors, indicating that not only HSCs but also Kupffer and endothelial cells are target cells. IL10 did not bind to these receptors. We conclude that we prepared an active and liver-specific form of the cytokine IL10 that can be evaluated for its efficacy to treat liver diseases. |
| | |
Authors:
|
Heni Rachmawati; Catharina Reker-Smit; Marjolijn N Lub-de Hooge; Annemiek van Loenen-Weemaes; Klaas Poelstra; Leonie Beljaars |
Related Documents
:
|
19457567 - Apoptotic body engulfment by hepatic stellate cells promotes their survival by the jak/... 7959567 - The potential role of reactive oxygen species in liver ischemia/reperfusion injury foll... 16403957 - Possible involvement of 4-hydroxynonenal in splenocyte regulated liver regeneration. 2953387 - An ultrastructural and histochemical study of the prominent inflammatory response in d(... 20603617 - The unexpected role of lymphotoxin beta receptor signaling in carcinogenesis: from lymp... 1647897 - A new method for assessment of cultured cardiac myocyte contractility detects immune fa... |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't Date: 2007-02-20 |
Journal Detail:
|
Title: Drug metabolism and disposition: the biological fate of chemicals Volume: 35 ISSN: 0090-9556 ISO Abbreviation: Drug Metab. Dispos. Publication Date: 2007 May |
Date Detail:
|
Created Date: 2007-04-20 Completed Date: 2007-10-11 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9421550 Medline TA: Drug Metab Dispos Country: United States |
Other Details:
|
Languages: eng Pagination: 814-21 Citation Subset: IM |
Affiliation:
|
Dept. of Pharmacokinetics and Drug Delivery, University of Groningen, A. Deusinglaan 1, 9713 AV Groningen, The Netherlands. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Animals Blotting, Western Cell Line Dose-Response Relationship, Drug Immunohistochemistry / methods Injections, Intravenous Interleukin-10 / administration & dosage, chemistry, pharmacokinetics* Iodine Radioisotopes Kidney / metabolism Lipopolysaccharides / pharmacology Liver / metabolism* Liver Cirrhosis, Experimental / chemically induced, metabolism Macrophages / cytology, drug effects, metabolism Male Mannosephosphates / chemistry* Molecular Structure Rats Rats, Wistar Tissue Distribution Tumor Necrosis Factor-alpha / metabolism |
| Chemical | |
Reg. No./Substance:
|
0/Iodine Radioisotopes; 0/Lipopolysaccharides; 0/Mannosephosphates; 0/Tumor Necrosis Factor-alpha; 130068-27-8/Interleukin-10; 3672-15-9/mannose-6-phosphate |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Progenitor cell isolation from muscle-derived cells based on adhesion properties.
Next Document: Kinetic analysis of the transport of salicylic acid, a nonsteroidal anti-inflammatory drug, across h...